Chemoinformaics analysis of Pyridine, 3-(5-(p-methoxyphenyl)-2-oxazolyl)-
| Molecular Weight | 252.273 | nRot | 3 |
| Heavy Atom Molecular Weight | 240.177 | nRig | 17 |
| Exact Molecular Weight | 252.09 | nRing | 3 |
| Solubility: LogS | -3.537 | nHRing | 2 |
| Solubility: LogP | 3.168 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 17 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 17 |
| nHA | 4 | APOL | 36.8555 |
| nHD | 0 | BPOL | 17.7905 |
| QED | 0.716 |
| Synth | 1.942 |
| Natural Product Likeliness | -1.038 |
| NR-PPAR-gamma | 0.03 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.978 |
| Pgp-sub | 0.002 |
| HIA | 0.006 |
| CACO-2 | -4.453 |
| MDCK | 0.0000175 |
| BBB | 0.801 |
| PPB | 0.936869 |
| VDSS | 2.973 |
| FU | 0.0588828 |
| CYP1A2-inh | 0.986 |
| CYP1A2-sub | 0.608 |
| CYP2c19-inh | 0.945 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.62 |
| CYP2c9-sub | 0.884 |
| CYP2d6-inh | 0.9 |
| CYP2d6-sub | 0.865 |
| CYP3a4-inh | 0.96 |
| CYP3a4-sub | 0.25 |
| CL | 8.01 |
| T12 | 0.27 |
| hERG | 0.115 |
| Ames | 0.014 |
| ROA | 0.39 |
| SkinSen | 0.182 |
| Carcinogencity | 0.707 |
| EI | 0.171 |
| Respiratory | 0.251 |
| NR-Aromatase | 0.974 |
| Antiviral | Yes |
| Prediction | 0.529843 |